IRIS
BELLONE, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.160
EU - Europa 5.949
AS - Asia 3.144
SA - Sud America 957
Continente sconosciuto - Info sul continente non disponibili 353
AF - Africa 102
OC - Oceania 3
Totale 16.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.937
RU - Federazione Russa 3.192
SG - Singapore 1.355
CN - Cina 845
BR - Brasile 784
IT - Italia 652
IE - Irlanda 626
SE - Svezia 540
HK - Hong Kong 352
DE - Germania 247
FR - Francia 203
VN - Vietnam 172
PL - Polonia 104
GB - Regno Unito 98
FI - Finlandia 97
IN - India 94
CA - Canada 82
BD - Bangladesh 55
AR - Argentina 42
EC - Ecuador 41
NL - Olanda 37
MX - Messico 35
TR - Turchia 35
AT - Austria 33
IQ - Iraq 31
BE - Belgio 28
CO - Colombia 28
ZA - Sudafrica 27
ES - Italia 25
ID - Indonesia 24
JP - Giappone 23
PK - Pakistan 20
UZ - Uzbekistan 20
CL - Cile 18
HN - Honduras 18
GT - Guatemala 16
CI - Costa d'Avorio 14
CR - Costa Rica 14
MA - Marocco 14
VE - Venezuela 14
JM - Giamaica 13
MY - Malesia 13
EG - Egitto 12
KR - Corea 12
PY - Paraguay 12
UA - Ucraina 12
SA - Arabia Saudita 11
TT - Trinidad e Tobago 11
LT - Lituania 10
IL - Israele 9
JO - Giordania 9
NI - Nicaragua 9
PH - Filippine 9
EE - Estonia 8
GP - Guadalupe 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
AZ - Azerbaigian 6
NG - Nigeria 6
NO - Norvegia 6
PE - Perù 6
SC - Seychelles 6
UY - Uruguay 6
BH - Bahrain 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
TN - Tunisia 5
AL - Albania 4
BO - Bolivia 4
DZ - Algeria 4
GE - Georgia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NP - Nepal 4
OM - Oman 4
TH - Thailandia 4
AU - Australia 3
KE - Kenya 3
LK - Sri Lanka 3
SV - El Salvador 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
LB - Libano 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
Totale 16.303
Salva come PNG Salva come JPEG
Città #
Ashburn 1.044
Moscow 875
Singapore 706
Dublin 622
Dallas 517
Chandler 498
San Jose 447
Hong Kong 311
Nyköping 308
Beijing 242
Messina 189
Council Bluffs 163
The Dalles 141
New York 125
Munich 124
Los Angeles 118
Princeton 105
Warsaw 96
Dearborn 94
Lauterbourg 91
Medford 77
São Paulo 71
Ann Arbor 70
Jacksonville 62
Ho Chi Minh City 59
Catania 58
Boardman 56
Des Moines 55
Santa Clara 53
Buffalo 49
Bremen 45
Guangzhou 41
Turku 39
Shenyang 38
Atlanta 37
Cambridge 35
Helsinki 34
Redondo Beach 34
Houston 33
Seattle 33
Milan 32
Orem 32
Jinan 29
Chicago 28
Rome 28
Wilmington 28
Brussels 27
Tianjin 26
Curitiba 24
Hanoi 24
Montreal 24
Frankfurt am Main 23
Phoenix 23
Nanjing 22
North Bergen 22
Belo Horizonte 21
Nuremberg 21
Pune 21
San Francisco 21
Rio de Janeiro 20
Chennai 19
Düsseldorf 19
Strasbourg 19
Boston 18
Brooklyn 18
Brasília 17
San Mateo 17
Tashkent 17
Amsterdam 16
Columbus 16
Denver 16
Shanghai 16
Tokyo 16
Nanchang 15
Porto Alegre 15
Quito 15
Abidjan 14
Hebei 14
Johannesburg 14
Mexico City 14
Naples 14
Palermo 14
Vienna 14
Guayaquil 13
Mumbai 13
Poplar 13
Zhengzhou 13
Falls Church 12
Goiânia 12
Toronto 12
Baghdad 11
Central 11
Fremont 11
Guatemala City 11
London 11
Manchester 11
Newark 11
Ningbo 11
San José 11
Stockholm 11
Totale 8.856
Salva come PNG Salva come JPEG
Nome #
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 302
Anxiety levels as risk factor for osteoporosis in postmenopausal women 284
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 263
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 253
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 243
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 242
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 235
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 232
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 232
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 226
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 223
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 222
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 217
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 217
Association between cognitive reserve dimensions and frailty among older adults: A structured narrative review 212
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 211
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 203
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 203
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 203
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 200
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 198
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 196
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 196
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 195
Alexithymia and inflammatory bowel disease: A systematic review 195
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 194
Multiple osteoporotic fractures complicating Wolfram syndrome 193
Hyponatremia as a leading sign of hypopituitarism 190
Association between anxiety levels and osteoporosis in postmenopausal women. 189
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 180
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 175
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 175
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 174
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 173
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 173
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 172
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 171
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link? 170
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 170
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 169
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 167
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 167
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 163
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 162
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 158
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 158
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 158
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 155
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 154
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 152
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 151
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 147
Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life 147
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 146
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 145
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 143
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 143
Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis 142
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 140
Quality of life in postmenopausal women: Which role for vitamin D? 139
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 139
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 138
Pain and Frailty in Hospitalized Older Adults 137
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 136
Health related quality of life and anxiety in patients with Type 2 Diabetes Mellitus 136
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 135
Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D 134
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 133
The association between hypoparathyroidism and cognitive impairment: a systematic review 131
Bone quality is associated with body composition measurements in patients with type 2 diabetes. 130
EFFETTO CODA DI ALENDRONATO SULLA DENSITÀ MINERALE OSSEA IN DONNE CON OSTEOPOROSI POSTMENOPAUSALE: POSSIBILE RUOLO DELLA VITAMINA D 129
Changes in Cognitive and Functional Status and in Quality of Life of Older Outpatients during the COVID-19 Pandemic 128
PULSED ELECTROMAGNETIC FIELDS MODULATE SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 127
Vitamin D, bone metabolism, and fracture risk in polycystic ovary syndrome 123
An unusual bilateral groin pain after COVID-19 infection in an 82-year-old man 120
VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE 120
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 118
Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease 115
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 115
Vitamin d boosts alendronate tail effect on bone mineral density in postmenopausal women with osteoporosis 113
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 112
Unlocking the Predictive Power of Nutritional Scores in Septic Patients 112
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 111
IMPATTO DEI LIVELLI DI ANSIA SULLA DENSITÀ MINERALE OSSEA IN DONNE IN POSTMENOPAUSA IN TRATTAMENTO CON BIFOSFONATI ORALI: RISULTATI DI UNO STUDIO DI COORTE LONGITUDINALE 111
Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease 107
Effects of denosumab on insulin resistance in postmenopausal women with osteoporosis 105
IL PAZIENTE ANZIANO CON MALATTIA INFIAMMATORIA CRONICA INTESTINALE: OSSERVAZIONI IN UN GRUPPO DI PAZIENTI AMBULATORIALI 99
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now 94
Psychological factors may impact on postmenpausal women fracture risk 93
Is the Pentagon-Copying Task More than a Cognitive Feature? Associations with Handgrip Strength, Gait Speed, and Frailty in Older Adults 93
Vitamin D as predictor of anxiety levels in postmenopausal women. 92
Rates of hypomagnesemia and hypermagnesemia in medical settings 89
Magnesium disorders: Myth or facts? 88
POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN 87
Sclerostin and vascular pathophysiology 85
SUN-343 Prevalence and Incidence of Hypomagnesemia and Hypermagnesemia in Medical Settings 84
Executive functions predict fracture risk in postmenopausal women assessed for osteoporosis 82
Nutraceuticals as Alternative Approach against Cadmium-Induced Kidney Damage: A Narrative Review 81
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 79
IMPACT OF ANXIETY LEVELS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH ORAL BIPHOSPHONATES: RESULTS FROM A LONGITUDINAL COHORT STUDY 79
Totale 15.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022670 0 0 0 0 17 13 106 38 76 127 53 240
2022/20231.822 138 197 92 143 135 156 21 93 743 20 61 23
2023/2024658 33 82 33 71 45 140 33 88 3 13 22 95
2024/20252.637 66 51 44 177 146 92 88 452 597 233 230 461
2025/20267.858 433 544 522 482 680 1.556 994 1.022 971 366 126 162
2026/20271.796 201 656 342 526 71 0 0 0 0 0 0 0
Totale 16.668